Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Amino Acids, Essential
  • Exercise
  • Metabolism
Type
Interventional
Phase
Phase 1
Design
Allocation: RandomizedIntervention Model: Crossover AssignmentIntervention Model Description: In a randomized, counterbalanced order, participants will receive all treatments arms (essential amino acids, branched-chain amino acids, and placebo).Masking: Triple (Participant, Investigator, Outcomes Assessor)Masking Description: All investigators involved with the study, as well as participants, will be blinded to treatment conditions (double-blind design) until data analysis is completed.Primary Purpose: Basic Science

Participation Requirements

Age
Between 18 years and 35 years
Gender
Only males

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT04850820
Collaborators
Iovate Health Sciences International Inc
Investigators
Principal Investigator: Daniel Moore University of Toronto